Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors

Saved in:
Bibliographic Details
Published inJNCI : Journal of the National Cancer Institute Vol. 83; no. 19; p. 1408
Main Authors Baars, J W, Wagstaff, J, Boven, E, Vermorken, J B, van Groeningen, C J, Scheper, R J, Fonk, J C, Nijman, H W, Franks, C R, Damsma, O
Format Journal Article
LanguageEnglish
Published United States 02.10.1991
Subjects
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Drug Administration Schedule
Drug Evaluation
Female
Humans
Interferon-gamma - administration & dosage
Interferon-gamma - adverse effects
Interleukin-2 - administration & dosage
Interleukin-2 - adverse effects
Male
Middle Aged
Neoplasm Metastasis
Neoplasms - drug therapy
Recombinant Proteins - administration & dosage
Online AccessGet more information

Cover

More Information
ISSN:0027-8874
DOI:10.1093/jnci/83.19.1408